Quandt, Jacqueline

Portrait photo of Jacqueline Quandt


Quandt, Jacqueline

BSc, PhD (UBC)

Lab Website

Basic Info

Academic Rank:

Assistant Professor, Dept of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia


Centre for Brain Health


UBC Hospital

Short Bio

Dr. Jacqueline Quandt is the Associate Director of the UBC MS Research Group at UBC and leads the Neuroinflammation Lab at the Djavad Mowafaghian Centre for Brain Health and the Department of Pathology in the Faculty of Medicine. Her research is focused on understanding the role of the immune system in both damage and repair of the brain and spinal cord as a result of neurodegenerative diseases, such as Multiple Sclerosis. Using cell-based and more complex disease models, researchers in the Quandt Lab study the relationships between inflammation and neuronal death.


Academic Backgrounds

  • BSc (Microbiology and Immunology), University of British Columbia. 1990-1994
  • PhD (Pathology, Section of Neuropathology), University of British Columbia. 1994-1999
  • Post doctoral fellowship (Neuroimmunology Branch), National Institutes of Health, Bethesda, MD. 1999-2005
  • Staff Scientist – Animal Models Unit (Neuroimmunology Branch), National Institutes of Health, Bethesda, MD. 2005-2009

Awards & Recognition

Selected Publications

View Dr. Verchere’s PubMed record here


Current Openings & Opportunities

The Laboratory currently has openings for a graduate student and a post doctoral fellow to pursue independent projects in the areas of neuroinflammation and models of disease. Interested candidates should send their CV and statement of research interests directly to Dr. Quandt.

Current Projects In My Lab include


  • Brain Injury & Repair
  • Sensory/Motor Systems & Movement Disorders

The Quandt lab’s current projects are diverse, but most apply molecular and cellular techniques in cell and disease models to study the way that inflammatory cells contribute to disease development. Having made significant contributions to MS research, the lab is now pursuing discovery in a range of neurodegenerative diseases.